Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison for prevention of shivering during spinal anesthesia in cesarean section
IRCT20160307026950N17Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Shivering. Started Feb 2020; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on IRCT20160307026950N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N17.